-
Special Interest Groups
- Biosimilars
- Clinical Outcome Assessment
- Digital Health
- Health Preference Research
- Medical Devices and Diagnostics
-
Medication Adherence and Persistence
-
Nutrition Economics
- Oncology
- Open Source Models
- Patient-Centered
- Precision Medicine and Advanced Therapies
- Rare Disease
- Real-World Evidence (RWE)
- Statistical Methods in HEOR
-
Task Forces
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) II
- Joint HTAi - ISPOR Deliberative Processes for HTA
- Machine Learning Methods in HEOR
- Measurement Comparability Between Modes of Administration of PROMs
- Measuring Patient Preferences for Decision Making
- Performance Outcome (PerfO) Assessments
- Systematic Reviews with Cost and Cost-Effectiveness Outcomes
- Joint ISPE-ISPOR Special Task Force
- Councils & Roundtables
- Global Groups
- Students
-
New Professionals
-
Professional Development Resources
- What is the Impact of GDPR on the HEOR Community
- Good Practices for HTA - What is out there and how do I use it
- ISPOR & AACP Joint Webinar – “Tips for Securing a Post-Doctoral Fellowship”
- You Are Creative: Research is the First Step
- AMCP eDossier System @ FormularyDecisions.com Demo and Practical Application
- Good Practices for a Successful Job Search
- Leveraging The Power Of LinkedIn
- Internships & Fellowships: Career Opportunities for the Future
- My Career Path
- Career Advice Across the Globe
- "My ISPOR Story" - Zeba Khan
- "My ISPOR Story" - Lou Garrison
- Replicate, Regulate, and Redefine: RWE use cases in the next decade
-
Professional Development Resources
Mission
To provide leadership and a multi-stakeholder, collaborative platform for the Medical Device and Diagnostic community to address opportunities, issues and challenges impacting the policy, economic evaluation, and payment landscape for the device and diagnostic space.
Goal
- Develop and disseminate best practices in outcome research of medical technologies
- Promote scientific discussions on relevant topics for devices and diagnostics
- Prioritize, develop and promote research and education related to medical devices and diagnostics.
- Provide an international network of stakeholders to advance the validation, adoption and utilization of medical devices and diagnostics.
Background
Medical devices and diagnostics account for roughly a quarter of hospital technology expenditures and are a rapidly growing technology field. There is a broad group of stakeholders affected by the medical device and diagnostics marketplace that is relevant to ISPOR, including scientists, economists, manufacturers, policy makers, clinicians, HTA organizations, payers, procurement, media, advocacy organizations and patients. Efforts to define market value of medical devices and diagnostics are confounded by several factors especially a scarcity of verifiable evidence in the early and mid-stages of product commercialization. Difficulty in performing timely and reliable assessments compounded with fragmented and diverse payment pathways, can limit market access and reimbursement. It is critical to advance this dialogue with multiple stakeholders to ensure appropriate provider and patient access, while ensuring healthcare system value for money.
Leadership:
Richard Charter, MSc
Ulises Garay, MSc, BEc, MD
Working Groups:
Key Project
Value Assessment of Medical Device
Submitted to Value in Health
Member Engagement
Co-chairs:
- Rituparna Bhattacharya, MS, PhD, Research Science Lead, Humana Healthcare Research, Humana Inc
- Bjoern Schwander, RN, BSc, MA General Manager, AHEAD GmbH
- Abdalla Abotaleb, BSc, MBA, PhD, Project Manager, WHO
Book of terms:
- Mriga Shrikhande